Artivion (AORT) | Stock Overview & Key Data
Artivion Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $48.25 on December 17, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Artivion
AORT
|
1.83B Small-cap | 3.33% | -7.47% | -43.66% | -53.56% | -52.61% | -28.85% | 25.55% | -29.37% | 70.34% | 288.03% | 318.75% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Axogen
AXGN
|
1.94B Small-cap | 5.50% | 6.71% | 33.19% | 46.88% | 41.10% | 341.03% | 367.90% | 106.53% | 628.81% | 1,769.57% | 12,185.71% |
|
Establishment Labs
ESTA
|
1.91B Small-cap | 12.52% | 28.06% | 32.66% | 16.91% | 22.33% | 119.39% | 25.90% | 5.07% | 211.25% | 211.25% | 211.25% |
|
AdaptHealth
AHCO
|
1.73B Small-cap | 7.24% | 7.35% | -13.43% | 5.38% | 13.34% | 18.14% | 0.59% | -63.29% | 4.74% | 4.74% | 4.74% |
Ownership & Short Interest
Calculate Your Artivion Investment Returns
Long-Term Investment Performance Analysis
Artivion stock price in Jul 2016 was $12.00, A $1,000.00 lump sum investment in Artivion made 9 years ago would be worth approximately $1,755.83 today, representing a solid return of 75.58%. This translates to an annualized return (CAGR) of 5.85%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is AORT's 52-week high and low?
- In the last 52 weeks, Artivion reached a high of $48.25 (on December 17, 2025) and a low of $19.16 (on May 8, 2026).
- What is the market cap and P/E ratio for AORT?
- Curious about Artivion's size and valuation? Its market capitalization stands at 1.83B. When it comes to valuation, the P/E ratio (trailing twelve months) is 179.71, and the forward P/E (looking ahead) is 32.65.
- Does AORT pay dividends? If so, what's the yield?
- As for dividends, Artivion isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Artivion's main competitors or similar companies to consider before investing?
When looking at Artivion, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Axogen
AXGN1.94B Healthcare Medical Devices 341.03% 367.90% Establishment Labs
ESTA1.91B Healthcare Medical Devices 119.39% 25.90% AdaptHealth
AHCO1.73B Healthcare Medical Devices 18.14% 0.59% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Artivion Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Artivion's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.70%, the Debt to Equity ratio from the most recent quarter is 57.67, and its Gross Profit Margin stands at 63.06%.
- What is the recent revenue and earnings growth for AORT?
- Looking at Artivion's growth, its revenue over the trailing twelve months (TTM) was $441M. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.20%, and quarterly earnings saw a YoY growth of 19.20%.
- How much of AORT stock is held by insiders and institutions?
- Wondering who owns Artivion stock? Company insiders (like executives and directors) hold about 4.52% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 91.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.